126 related articles for article (PubMed ID: 9537579)
1. Expression of epidermal growth factor receptor in urinary bladder cancer metastases.
Bue P; Wester K; Sjöström A; Holmberg A; Nilsson S; Carlsson J; Westlin JE; Busch C; Malmström PU
Int J Cancer; 1998 Apr; 76(2):189-93. PubMed ID: 9537579
[TBL] [Abstract][Full Text] [Related]
2. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.
Wright C; Mellon K; Johnston P; Lane DP; Harris AL; Horne CH; Neal DE
Br J Cancer; 1991 Jun; 63(6):967-70. PubMed ID: 1712624
[TBL] [Abstract][Full Text] [Related]
3. Significance of epidermal growth factor receptor and c-erbB-2 protein expression in transitional cell cancer of the upper urinary tract for tumour recurrence at the urinary bladder.
Imai T; Kimura M; Takeda M; Tomita Y
Br J Cancer; 1995 Jan; 71(1):69-72. PubMed ID: 7819052
[TBL] [Abstract][Full Text] [Related]
4. Profile of epidermal growth factor receptor (EGFr) expression in human malignancies: effects of exposure to EGF and its biological influence on established human tumour cell lines.
Nouri AM; Thompson C; Cannell H; Symes M; Purkiss S; Amirghofran Z
Int J Mol Med; 2000 Oct; 6(4):495-500. PubMed ID: 10998445
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Epidermal Growth Factor Receptor (EGFR) and HER-2 in Bladder Carcinoma and Its Association with Patients' Clinical Features.
Li W; Wang Y; Tan S; Rao Q; Zhu T; Huang G; Li Z; Liu G
Med Sci Monit; 2018 Oct; 24():7178-7185. PubMed ID: 30296252
[TBL] [Abstract][Full Text] [Related]
6. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
Lipponen P; Eskelinen M
Br J Cancer; 1994 Jun; 69(6):1120-5. PubMed ID: 7911031
[TBL] [Abstract][Full Text] [Related]
7. HER-2--a possible target for therapy of metastatic urinary bladder carcinoma.
Wester K; Sjöström A; de la Torre M; Carlsson J; Malmström PU
Acta Oncol; 2002; 41(3):282-8. PubMed ID: 12195748
[TBL] [Abstract][Full Text] [Related]
8. Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis.
Nguyen PL; Swanson PE; Jaszcz W; Aeppli DM; Zhang G; Singleton TP; Ward S; Dykoski D; Harvey J; Niehans GA
Am J Clin Pathol; 1994 Feb; 101(2):166-76. PubMed ID: 7906919
[TBL] [Abstract][Full Text] [Related]
9. Protein networking in bladder cancer: immunoreactivity for FGFR3, EGFR, ERBB2, KAI1, PTEN, and RAS in normal and malignant urothelium.
Røtterud R; Fosså SD; Nesland JM
Histol Histopathol; 2007 Apr; 22(4):349-63. PubMed ID: 17290345
[TBL] [Abstract][Full Text] [Related]
10. THE SIGNIFICANCE OF EPIDERMAL GROWTH FACTOR RECEPTOR AND SURVIVIN EXPRESSION IN BLADDER CANCER TISSUE AND URINE CYTOLOGY OF PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER.
Kehinde EO; Al-Maghrebi M; Anim JT; Kapila K; George SS; Al-Juwaiser A; Memon A
East Afr Med J; 2013 Jan; 90(1):19-27. PubMed ID: 26862626
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinomas, an immunohistochemical and ultrastructural study.
Suo Z; Holm R; Nesland JM
Anticancer Res; 1992; 12(6B):2025-31. PubMed ID: 1284199
[TBL] [Abstract][Full Text] [Related]
12. Expression of the epidermal growth factor receptor family in normal and malignant urothelium.
Røtterud R; Nesland JM; Berner A; Fosså SD
BJU Int; 2005 Jun; 95(9):1344-50. PubMed ID: 15892828
[TBL] [Abstract][Full Text] [Related]
13. Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours.
Neal DE; Marsh C; Bennett MK; Abel PD; Hall RR; Sainsbury JR; Harris AL
Lancet; 1985 Feb; 1(8425):366-8. PubMed ID: 2857420
[TBL] [Abstract][Full Text] [Related]
14. Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases.
Gårdmark T; Wester K; De la Torre M; Carlsson J; Malmström PU
BJU Int; 2005 May; 95(7):982-6. PubMed ID: 15839918
[TBL] [Abstract][Full Text] [Related]
15. Late penile metastasis from primary bladder carcinoma.
Berger AP; Rogatsch H; Hoeltl L; Steiner H; Bartsch G; Hobisch A
Urology; 2003 Jul; 62(1):145. PubMed ID: 12837452
[TBL] [Abstract][Full Text] [Related]
16. Metastatic patterns of bladder carcinoma.
Tabbara WS; Mehio AR
Prog Clin Biol Res; 1984; 162A():145-60. PubMed ID: 6483906
[TBL] [Abstract][Full Text] [Related]
17. The immunocytochemical demonstration of basement membrane deposition in transitional cell carcinoma of bladder.
Zuk RJ; Baithun SI; Martin JE; Cox EL; Revell PA
Virchows Arch A Pathol Anat Histopathol; 1989; 414(5):447-52. PubMed ID: 2499101
[TBL] [Abstract][Full Text] [Related]
18. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
19. Expression patterns of erbB receptor family in normal urothelium and transitional cell carcinoma. An immunohistochemical study.
Chow NH; Liu HS; Yang HB; Chan SH; Su IJ
Virchows Arch; 1997 Jun; 430(6):461-6. PubMed ID: 9230911
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor, MUC-1 and MUC-2 in bladder cancer.
Cardillo MR; Castagna G; Memeo L; De Bernardinis E; Di Silverio F
J Exp Clin Cancer Res; 2000 Jun; 19(2):225-33. PubMed ID: 10965823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
